Published: Monday, March 04, 2013 Last Updated: Monday, March 04, 2013
Scientists at Yale University have designed and tested a drug delivery system that shows early promise for improved treatment of lupus and other chronic, uncured autoimmune diseases, such as multiple sclerosis and Type 1 diabetes.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.